Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/06/043013
CTRI/2022/06/043013
Completed
Phase 2

A Randomized, Prospective, Comparative Clinical Study to evaluate efficacy and safety of NANSHO Hair Oil in mild to moderate Hair loss in females. - NI

amaskar Ayurved Private Limited0 sites71 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L659- Nonscarring hair loss, unspecified

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L659- Nonscarring hair loss, unspecified
Sponsor
amaskar Ayurved Private Limited
Enrollment
71
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 6, 2022
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
amaskar Ayurved Private Limited

Eligibility Criteria

Inclusion Criteria

  • •1\.Subjects suffering from mild to moderate hair loss (40\-140 Hair by Comb test and Finger Test).
  • •2\.Subjects who are infrequent hair oil users
  • •3\.Subjects who are willing to give informed consent and ready to comply with the protocol
  • •4\.Subjects who are ready to provide regular follow ups till the completion of the study.

Exclusion Criteria

  • •1\.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc.
  • •2\.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation
  • •3\.Subjects with recent disease history like, malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study
  • •4\.Subjects who have regularly used anti\-hair fall treatment with hair oils over the last 6 months.
  • •5\.Subjects who have previously undergone hair transplantation procedures
  • •6\.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
  • •7\.Subjects on immunosuppressive drugs
  • •8\.Known cases of Hypersensitivity to hair oil contents
  • •9\.Subjects who have participated in any other clinical study since last 3 months
  • •10\.Subjects who are reported pregnant/planning a pregnancy or lactating.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
A clinical study to compare the ayurvedic medicine Medhavati with allopathic medicine sertraline for the treatment of Depression.Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
CTRI/2020/06/025741ational Institute of Medical Sciences Research Jaipur
Not yet recruiting
Phase 4
To compare and evaluate the safety, efficacy and refractive outcome of three different Hydrophilic Monofocal Intraocular Lens implanted to cataract patients.Health Condition 1: H259- Unspecified age-related cataract
CTRI/2019/12/022318Biotech Vision Care Pvt Ltd
Not yet recruiting
Phase 4
A COMPARISON OF EFFICACY AND SAFETY OF KAYA KALPA VATI AND SEABUCK THORN OIL WITH ORAL METHOTREXATE AND TOPICAL STEROID IN CHRONIC PLAQUE PSORIASISHealth Condition 1: L400- Psoriasis vulgaris
CTRI/2020/06/025658ational Institute of Medical Sciences and Research Centre
Not yet recruiting
Not Applicable
A prospective, randomized and comparative clinical study to evaluate the efficacy and safety of the plasma-activated water on vaginitis and improving vaginal environment using a plasma vaginal irrigator (WOMEN CARE) in female patients with (suspected) vaginitis
KCT0009616Hanyang University Guri Hospital114
Not yet recruiting
Phase 1
Role of agni karma and vishwadi guggulu in pain management of sciatica.Health Condition 1: G570- Lesion of sciatic nerveHealth Condition 2: G570- Lesion of sciatic nerveHealth Condition 3: G541- Lumbosacral plexus disorders
CTRI/2023/06/053445Dr Shikha Verma